Is inositol a potential therapy for abdominal aortic aneurysm? (Old ID 22440)

Principal Investigator

AIMS: Preliminary data demonstrate that inositol consumption limits experimental AAA development. This project builds on initial findings using the following aims: assess the ability of inositol to limit AAA growth (Aim 1) and rupture (Aim 2) in mouse models. SIGNIFICANCE: Identifying a drug to slow AAA growth and limit rupture has potential to improve patient care and reduce in-hospital costs associated with AAA management. OUTCOMES: This study will underpin competitive funding applications to the NHMRC and/or NFHMRI to further assess inositol status in human AAA patients.

01 Dec 2015 - 31 Dec 2017

N/A